RE:RE:RE:RE:RE:RE:CG Oncology phase 3 results impossible for TLT to beat?Why should TLT get BTD with this out there? Having lots of treatments and working with Keytruda is the exact sweet spot big pharma wants, hence their big money backers.
Hard not to see this as a dagger to TLT. As I've said before, if it has a high success rate, no one, especially patients, cares about number of treatments. That's what pharma wants anyway.